Great DD Alex. I also read those on the VIAP site about a week ago and thought it was really to good to be true. Hopefully it isn't and I hope this Biotech will be an insane 10 bagger.
The only problem I foresee is that who will continue to fund their operations if the results of the upcoming data for the clinical trials don't meet par. For anyone whos going short on this company should watch for this as I will be.
A little something that gave me some insight on all biotechs in general.